Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium

Abstract

Phosphatase and tensin homolog (PTEN) is one of the most frequently mutated tumor suppressor genes in cancers. PTEN has a central role in phosphatidylinositol (3,4,5)-trisphosphate (PIP3) signaling and converts PIP3 to phosphatidylinositol (4,5)-bisphosphate at the plasma membrane. Despite its importance, the mechanism that mediates membrane localization of PTEN is poorly understood. Here, we generated a library that contains green fluorescent protein fused to randomly mutated human PTEN and expressed the library in Dictyostelium cells. Using live cell imaging, we identified mutations that enhance the association of PTEN with the plasma membrane. These mutations were located in four separate regions, including the phosphatase catalytic site, the calcium-binding region 3 (CBR3) loop, the Cα2 loop and the C-terminal tail phosphorylation site. The phosphatase catalytic site, the CBR3 loop and the Cα2 loop formed the membrane-binding regulatory interface and interacted with the inhibitory phosphorylated C-terminal tail. Furthermore, we showed that membrane recruitment of PTEN is required for PTEN function in cells. Thus, heterologous expression system in Dictyostelium cells provides mechanistic and functional insight into membrane localization of PTEN.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Hollander MC, Blumenthal GM, Dennis PA . PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 2011; 11: 289–301.

    Article  CAS  Google Scholar 

  2. Carracedo A, Alimonti A, Pandolfi PP . PTEN level in tumor suppression: how much is too little? Cancer Res 2011; 71: 629–633.

    Article  CAS  Google Scholar 

  3. Leslie NR, Dixon MJ, Schenning M, Gray A, Batty IH . Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases. Adv Biol Regul 2012; 52: 205–213.

    Article  CAS  Google Scholar 

  4. Rodon J, Dienstmann R, Serra V, Tabernero J . Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol 2013; 10: 143–153.

    Article  CAS  Google Scholar 

  5. Vanhaesebroeck B, Stephens L, Hawkins P . PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol 2012; 13: 195–203.

    Article  CAS  Google Scholar 

  6. Baker SJ . PTEN enters the nuclear age. Cell 2007; 128: 25–28.

    Article  CAS  Google Scholar 

  7. Song MS, Salmena L, Pandolfi PP . The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13: 283–296.

    Article  CAS  Google Scholar 

  8. Tamguney T, Stokoe D . New insights into PTEN. J Cell Sci 2007; 120 (Pt 23): 4071–4079.

    Article  CAS  Google Scholar 

  9. Rahdar M, Inoue T, Meyer T, Zhang J, Vazquez F, Devreotes PN . A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci USA 2009; 106: 480–485.

    Article  CAS  Google Scholar 

  10. Walker SM, Leslie NR, Perera NM, Batty IH, Downes CP . The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Biochem J 2004; 379 (Pt 2): 301–307.

    Article  CAS  Google Scholar 

  11. Denning G, Jean-Joseph B, Prince C, Durden DL, Vogt PK . A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth. Oncogene 2007; 26: 3930–3940.

    Article  CAS  Google Scholar 

  12. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 1999; 99: 323–334.

    Article  CAS  Google Scholar 

  13. Das S, Dixon JE, Cho W . Membrane-binding and activation mechanism of PTEN. Proc Natl Acad Sci USA 2003; 100: 7491–7496.

    Article  CAS  Google Scholar 

  14. Iijima M, Devreotes P . Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 2002; 109: 599–610.

    Article  CAS  Google Scholar 

  15. Vazquez F, Matsuoka S, Sellers WR, Yanagida T, Ueda M, Devreotes PN . Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proc Natl Acad Sci USA 2006; 103: 3633–3638.

    Article  CAS  Google Scholar 

  16. Iijima M, Huang YE, Devreotes P . Temporal and spatial regulation of chemotaxis. Dev Cell 2002; 3: 469–478.

    Article  CAS  Google Scholar 

  17. Iijima M, Huang YE, Luo HR, Vazquez F, Devreotes PN . Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis. J Biol Chem 2004; 279: 16606–16613.

    Article  CAS  Google Scholar 

  18. Vazquez F, Ramaswamy S, Nakamura N, Sellers WR . Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 2000; 20: 5010–5018.

    Article  CAS  Google Scholar 

  19. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 1998; 95: 13513–13518.

    Article  CAS  Google Scholar 

  20. Shenoy S, Shekhar P, Heinrich F, Daou MC, Gericke A, Ross AH et al. Membrane association of the PTEN tumor suppressor: molecular details of the protein-membrane complex from SPR binding studies and neutron reflection. PLoS One 2012; 7: e32591.

    Article  CAS  Google Scholar 

  21. Lumb CN, Sansom MS . Defining the membrane-associated state of the PTEN tumor suppressor protein. Biophysical J 2013; 104: 613–621.

    Article  CAS  Google Scholar 

  22. Fey P, Kowal AS, Gaudet P, Pilcher KE, Chisholm RL . Protocols for growth and development of Dictyostelium discoideum. Nat Protoc 2007; 2: 1307–1316.

    Article  CAS  Google Scholar 

  23. Zhang P, Wang Y, Sesaki H, Iijima M . Proteomic identification of phosphatidylinositol (3,4,5) triphosphate-binding proteins in Dictyostelium discoideum. Proc Natl Acad Sci USA 2010; 107: 11829–11834.

    Article  CAS  Google Scholar 

  24. Chen CL, Wang Y, Sesaki H, Iijima M . Myosin I Links PIP3 signaling to remodeling of the actin cytoskeleton in chemotaxis. Sci Signaling 2012; 5: ra10.

    Article  Google Scholar 

  25. Cai H, Huang CH, Devreotes PN, Iijima M . Analysis of chemotaxis in Dictyostelium. Methods Mol Biol 2012; 757: 451–468.

    Article  Google Scholar 

  26. Wang Y, Steimle PA, Ren Y, Ross CA, Robinson DN, Egelhoff TT et al. Dictyostelium huntingtin controls chemotaxis and cytokinesis through the regulation of myosin II phosphorylation. Mol Biol Cell 2011; 22: 2270–2281.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by NIH grants to MI (GM084015), PND (GM28007 and GM34933) and HS (GM089853 and NS084154). We thank M Rahdar and KF Swaney for providing plasmids.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to P N Devreotes or M Iijima.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nguyen, H., Afkari, Y., Senoo, H. et al. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium. Oncogene 33, 5688–5696 (2014). https://doi.org/10.1038/onc.2013.507

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2013.507

Keywords

This article is cited by

Search

Quick links